Bond Screener
Johnson&Johnson
LEI 549300G0CFPGEF6X2043
Organization name
Johnson & Johnson
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
39,791 mln USD
New to Cbonds? · Take a 90-second tour of the platform.
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
|
General information
-
Organization nameJohnson & Johnson
-
Organization statusOperating organization
-
Site
-
IR Site
News
-
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results31/08/2026
-
Johnson&Johnson: Regulation Fd Disclosure, Financial Statements And Exhibits27/07/2026
-
Johnson&Johnson: Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibits23/04/2026
-
Johnson & Johnson (NYSE: JNJ) Reports Strong Q1 2026 Performance and Positive Outlook15/04/2026
-
Johnson & Johnson Beats Earnings And Raises Full-Year Guidance14/04/2026
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
Show more
Hide
Authorization required
You need to request access
